| Literature DB >> 31199293 |
David Hawig1, Chao Zhou1, Sebastian Fuhrhop1, Andre S Fialho1, Navin Ramachandran2.
Abstract
BACKGROUND: Distributed ledger technology (DLT) holds great potential to improve health information exchange. However, the immutable and transparent character of this technology may conflict with data privacy regulations and data processing best practices.Entities:
Keywords: FHIR; IOTA; IPFS; Masked Authenticated Messaging, MAM; blockchain; blood glucose; diabetes; directed acyclic graph; distributed ledger technology; mobile health
Mesh:
Substances:
Year: 2019 PMID: 31199293 PMCID: PMC6595943 DOI: 10.2196/13665
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Typical steps for current patient-provider exchange of continuous blood glucose (BG) data: (1) an adhesive patch holding the BG sensor is attached to the patient’s skin and measures glucose readings in interstitial fluid throughout the day and night; (2) the sensor sends real-time readings wirelessly to a receiver/smart device app, so the user can view the information; (3) the receiver or smart device app displays current and historical glucose levels and allows for this data to be printed and/or exported (eg, .txt file); and (4) the patient and provider review together the paper notes or exported files.
Figure 2Proposed steps for a distributed ledger technology (DLT)-based patient-provider exchange of blood glucose (BG) data: (1) an adhesive patch holding the BG sensor is attached to the patient’s skin and measures glucose readings in interstitial fluid throughout the day and night; (2) the sensor sends real-time readings wirelessly to a smart device app, so the user can view the information; (3) the smart device app displays current and historical glucose levels and is connected to an application programming interface (API; “MAM-FHIR API”) that allows for these data to be exported to a DLT; and (4) if a patient provides consent, the interoperable data stored on the DLT can be automatically exported to a physician’s electronic health record so that they can be reviewed.
Figure 3Proof-of-concept system for patient-provider exchange of blood glucose (BG) data with two variations: (1) public IOTA and (2) public IOTA plus private IPFS (InterPlanetary File System). EHR: electronic health record; FHIR: Fast Healthcare Interoperability Resources.
Figure 4Sequential block-based transactions of a blockchain (left) and IOTA directed acyclic graph-based transactions (right).
Figure 5The Masked Authenticated Messaging (MAM) root and channel key of the in-person key exchange.
Figure 6Anonymized JSON FHIR (JavaScript Object Notation Fast Healthcare Interoperability Resources) record stored on the public IOTA ledger with a pseudonymized ID consisting of the first 64 letters of the Masked Authenticated Messaging (MAM) root.
Figure 7Steps for a remote key exchange via a public key exchange. NTRU: Nth degree‐truncatedpolynomial ring units.
Transaction times for storing and logging anonymized records of Fast Healthcare Interoperability Resources on the public IOTA design and public IOTA plus private InterPlanetary File System (IPFS) design and remote key exchange times.
| Design and action | Trials | Time (ms), mean (SD) | Time (ms), range | Variance (ms2) | ||
| Create | 300 | 3525 (1182) | 2042-8100 | 1,397,997 | ||
| Attach | 300 | 2545 (765) | 1357-8923 | 584,728 | ||
| Create | 300 | 3636 (1371) | 2249-12,673 | 18,794,477 | ||
| Attach | 300 | 3522 (576) | 2161-5146 | 331,554 | ||
| Send request | 10 | 5160 (1801) | 3100-8500 | 3,247,111 | ||
| Accept request | 10 | 5790 (1253) | 4000-8500 | 1,572,111 | ||
Summary of the advantages and disadvantages of the two variations of the proposed proof-of-concept.
| Feature | Public IOTA | Public IOTA + private IPFSa |
| Reversal risk | N/Ab | Low |
| Linkability risk | Medium | Low |
| Processing time | Low | Low |
| File size compatibility | Small files | Any file size |
| Complexity | Low | Medium |
aIPFS: InterPlanetary File System.
bN/A: not applicable.